Protagenic Therapeutics, Inc. operates as a pharmaceutical company specializing in the development of medicines manufactured from cannabinoid and cannabinoid-like molecules. Protagenic Therapeutics, Inc. was founded in 2004 and is based in Santa Barbara, California. Show more

Location: 701 Anacapa Street, Santa Barbara, CA, 93101, United States | Website: https://phytanix.com | Industry: Biotechnology | Sector: Healthcare


Market Cap

6.30M

52 Wk Range

$2.25 - $15.26

Previous Close

$3.29

Open

$3.30

Volume

62,765

Day Range

$3.29 - $3.53

Enterprise Value

6.236M

Cash

0.00

Avg Qtr Burn

N/A

Insider Ownership

11.21%

Institutional Own.

10.11%

Qtr Updated

03/31/25


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date
PT00114 Details
Addiction, Post-traumatic stress disorder, Treatment Resistant Depression, Social Anxiety Disorder

Phase 1/2

Data readout